Sign in

Coronary artery disease

Current status: Treatable, not yet curable

A long-term heart condition in which fatty deposits narrow the arteries that feed the heart. It can cause chest pain and breathlessness during activity, but some people have no signs until a heart attack. It cannot be cured, but lifestyle changes, medicines and procedures can ease the symptoms and lower the risk of a heart attack. The risk rises with age, and men tend to get it earlier than women.

Read more about coronary artery disease
Where research stands todayUpdated 16 Nov 2026

Trial-stage treatments and research studies you can join

Filters

Country
City
Distance is calculated in your browser. Your city is not sent to us.
Type
Get notified of new trialsItaly, all cities, all phases
Your ageShows only trials that take people your age.
Phase
  1. Trial-stage treatmentPhase 3Soon in Italy
    Testing Low-Dose Colchicine for People With Peripheral Artery Disease

    Tests a low dose of colchicine, an anti-inflammatory pill, in adults with narrowed leg arteries.

    Padova, ItalyAge 18+
  2. Trial-stage treatmentPhase 3Soon in Italy
    Triple cholesterol therapy and coronary artery plaque in adults without prior heart events

    Tests bempedoic acid, ezetimibe and a statin on coronary plaque in adults.

    Milan, ItalyAlso Naples, NegrarAge 18+
  3. Trial-stage treatmentPhase 2/3Taking people
    Tests clazakizumab in adults with kidney failure on dialysis

    Tests clazakizumab against placebo in dialysis patients with heart disease or diabetes and inflammation.

    Bologna, ItalyAlso Brescia, Cagliari, Caserta, Catania, Ferrara, Florence, Foggia, Genova, …Age 18+
  4. Trial-stage treatmentPhase 4Taking people
    Shorter blood-thinner course after heart attack with ST-elevation

    Tests a shorter prasugrel blood-thinner course in people with ST-elevation heart attack.

    Bergamo, ItalyAlso Ferrara, Genova, Milan, Naples, Roma
  5. Trial-stage treatmentPhase 1/2Taking people
    Tests regadenoson safety in children with heart artery disease

    Tests regadenoson, a heart stress drug, in children and teens with heart disease.

    Roma, ItalyAge 0 to 18
  6. Trial-stage treatmentTaking people
    Compares two heart-bypass machine methods during heart surgery in adults

    Compares a minimally invasive bypass circuit with standard bypass in adults having heart surgery.

    Bari, ItalyAlso PalermoAge 18 to 85
  7. Trial-stage treatmentPhase 3Soon in Italy
    Ziltivekimab Compared With Placebo for Heart Artery Plaque After a Heart Attack

    Tests ziltivekimab against placebo for plaque in heart arteries after a heart attack.

    Bergamo, ItalyAlso Genova, Messina, Novara, Orbassano, Rivoli, Rome, San Donato MilaneseAge 18+
  8. Trial-stage treatmentPhase 2/3Taking people
    Tests ranolazine in people with a heart attack and narrowed heart arteries

    Tests ranolazine in adults with a heart attack and narrowed heart arteries.

    Catanzaro, ItalyAlso Latina, NaplesAge 18 to 80
  9. Trial-stage treatmentPhase 3Soon in Italy
    Early cholesterol pill combination with bempedoic acid after acute coronary syndrome

    Tests combined cholesterol pills with bempedoic acid after acute coronary syndrome.

    Acquaviva delle Fonti, ItalyAlso Arezzo, Avellino, Caserta, Catania, Ferrara, Florence, Foggia, Milan, …Age 18+
  10. Trial-stage treatmentPhase 2Taking people
    Tests orticumab for inflammation in heart arteries after a heart attack

    Tests orticumab against placebo in adults with prior heart attack and arterial inflammation.

    Brescia, ItalyAlso Caserta, Ferrara, Milan, PaviaAge 18+
  11. Trial-stage treatmentTaking people
    Single Versus Dual Antiplatelet Medicine After Heart Stent Balloon Treatment

    Compares one versus two blood-thinning medicines in older or high bleeding risk heart patients.

    Milan, Italy
  12. Trial-stage treatmentSoon in Italy
    Coated balloons versus drug stents for heart artery branch blockages

    Compares drug-coated balloons with drug-releasing stents in adults with coronary artery disease at a split.

    Milan, ItalyAge 18+
  13. Trial-stage treatmentTaking people
    Compares two balloon devices for narrowed heart arteries in adults

    Compares two drug-coated balloons used to open narrowed coronary arteries in adults.

    Bergamo, ItalyAlso Brescia, Ferrara, Mercogliano, Milan, Naples, Orbassano, Rivoli, Rozzano, …Age 18+
  14. Trial-stage treatmentTaking people
    Testing Genetic Risk Scores and Wearable Devices to Prevent Heart Disease

    Tests genetic risk testing and a wearable device app to prevent heart disease in adults.

    Roma, ItalyAge 40 to 69
  15. Trial-stage treatmentPhase 4Taking people
    Tests cangrelor against clopidogrel during elective heart stent procedures

    Tests cangrelor, a blood-thinning drug, in adults with coronary artery disease having stents.

    Ferrara, ItalyAlso NaplesAge 18+
  16. Trial-stage treatmentPhase 2Taking people
    Cangrelor blood thinner trial for heart attack patients on ECMO support

    Tests cangrelor with low-dose bivalirudin in adults with heart attack shock on ECMO.

    Milan, ItalyAge 18+
  17. Trial-stage treatment
    Tests pressure-wire guided stenting in people with coronary artery disease

    Tests pressure-wire guided stent placement in adults with heart artery narrowing.

    Florence, ItalyAge 18+
  18. Trial-stage treatmentPhase 4Taking people
    Tests short blood-thinner treatment after heart stenting in people with atrial fibrillation

    Tests one month of two antiplatelet drugs without anticoagulant in heart patients with atrial fibrillation.

    Bologna, ItalyAlso Florence, Novara, Parma, Pisa, Ravenna, Reggio EmiliaAge 18+
  19. Trial-stage treatmentPhase 3Taking people
    Tests two blood-thinning drug plans in people with coronary artery disease after bypass surgery

    Compares aspirin alone with aspirin plus ticagrelor in adults after heart bypass surgery.

    Rome, ItalyAge 18+
  20. Research studyTaking people
    Blood Markers of Aging and Heart Artery Plaque in Coronary Artery Disease

    Studies blood markers of cell aging in people with coronary artery disease and angina.

    Milan, ItalyAge 18 to 75

Trials that have ended are not listed here, because nobody can join them. Stopped and finished Coronary artery disease trials (research view)

Where treatment stands

There is no cure for coronary artery disease, but treatment can help manage the symptoms and lower the chance of problems such as heart attacks.

In the EU, colchicine was first approved in July 2026, not necessarily for this disease.

Approved: 71

Officially approved for this disease in the EU, the US, Switzerland or France.

Human testing stage: 31

Being tested in people. Many treatments at this stage are never approved.

Animal testing stage: 5

Worked in animals in a study published in the last 12 months. Most treatments at this stage never reach people.

Words used here

Placebo: a dummy treatment without the medicine, used for comparison.

Phase 1, 2, 3: the steps of testing in people. Phase 1 checks safety, phase 3 is the last step before approval.

Where this comes from

The EU medicines agency (EMA) and its list of medicines in the EU, US prescribing labels (DailyMed, openFDA), the Swiss medicines register (Swissmedic), the French medicines database (ANSM) and the Health Canada drug database, checked on 11 November 2026. Every medicine links to its own official text.

A computer made this list from the official texts: it kept only medicines whose own approval text names the disease, wrote "Who it is for" from that text and checked it against the text a second time. People have not reviewed it yet.

The trials: ClinicalTrials.gov and the EU trials register, as copied into our trial database, checked on 12 November 2026. Every treatment in trials links to its own trial records; the texts are written by AI from them and checked against them by a second AI. People have not reviewed them yet. Placebo, standard medicines used for comparison and procedures are left out.

Phase 3 trials are listed from every country; only some phase 2 trials are listed, so 46 other open phase 2 trials are not listed.

Animal and lab research: studies listed in PubMed and published in the 12 months before 12 November 2026, found by a search for coronary artery disease. AI chose the treatments from the study summaries and wrote the texts; a second AI checked each one against its study summary. People have not reviewed them yet. Treatments already in the approved or human testing lists are left out. A result in animals or cells does not show that a treatment works in people.

Not medical advice. Talk to your doctor before you change any treatment.

The approval records under a medicine come from Drugs@FDA and the FDA labels (openFDA) and from the EU medicines agency’s medicine data, with its orphan designations, checked on 13 Nov 2026. A date is the medicine’s first approval, for any use; the quoted text is its approved use as written today.

Support organisations

Patient organisations and helplines in Italy, for you and your family.

Coronary artery disease organisations in Italy

  • Fondazione Italiana per il Cuore ETS

    Funds cardiovascular research and prevention; public information on heart disease and healthy lifestyles.

  • Fondazione per il Tuo cuore – Heart Care Foundation ONLUS

    Italian non-profit heart foundation working on cardiovascular prevention, public information and research; member of the World Heart Federation.

  • Società Italiana per la Prevenzione Cardiovascolare (SIPREC)

    Casa della Prevenzione: cardiovascular risk assessment, videos, podcasts and citizen awareness campaigns.

  • SPELS ETS

    Science-based heart and brain health prevention: courses, online journal, podcasts, awareness materials.

General support in Italy

  • Telefono Amico Italia

    Italian volunteer emotional support service since 1967, listening to anyone in crisis or loneliness by phone (02 2327 2327), chat and WhatsApp.

International organisations

Patient organisation umbrella bodies

Offer tissue or data

There are three ways to help research move faster.

Give tissue or bloodA biobank stores your sample so many research teams can use it.No open programme yet
Share your health dataA patient registry collects your health data, without your name, for research.How to join
Take part as a healthy volunteerStudies also need people without the disease, for comparison. Family and friends can help.Volunteer

Approved treatments

75 medicines are approved for coronary artery disease in at least one of the places we checked. An approval in one place does not mean the medicine is offered or paid for where you live.

Checked on 11 Nov 2026 in the official lists of the US (FDA), the EU (EMA), Japan (PMDA, approvals since April 2004), Switzerland (Swissmedic), France (ANSM, medicines approved in France only) and Taiwan (TFDA). For Canada (Health Canada) and Singapore (HSA) we checked only whether a medicine is sold there, not what for. 24 uncertain matches are left out. Other countries' own approvals were not checked.

“Miracle cure” fact checker

Social media spreads misinformation. Paste here what you read, and we'll tell you whether there is scientific evidence behind it.

What you paste is checked with AI (Anthropic, USA) and is not stored. Please leave out names and other personal details.

Before you pay for anything, ask three things

  1. Is there a published study in people?
  2. Can I have the full price in writing?
  3. What does my doctor say?

“Cures” others already fact-checked

See all 4

About coronary artery disease

Sources: NHS, MedlinePlus

A long-term heart condition in which fatty deposits narrow the arteries that feed the heart. It can cause chest pain and breathlessness during activity, but some people have no signs until a heart attack. It cannot be cured, but lifestyle changes, medicines and procedures can ease the symptoms and lower the risk of a heart attack. The risk rises with age, and men tend to get it earlier than women.

What is it?

The coronary arteries carry blood and oxygen to the heart muscle. Over the years, fatty deposits containing cholesterol build up inside their walls (atherosclerosis). The arteries narrow, so the heart gets less blood than it needs, and a blockage can cause a heart attack. In some people, the heart's tiny blood vessels are damaged instead; this type is more common in women.

It is the most common type of heart disease in the United States and a leading cause of death for both men and women. The risk rises with age, and men tend to get it earlier. Smoking, high blood pressure, high cholesterol, diabetes, obesity and too little activity raise the risk. It runs in families: the risk is higher if a parent, brother or sister had heart disease before 50.

The first signs

Some people have no signs, and only find out when they have a heart attack. Signs may start or get worse when you are active or under stress, and may go away with rest.

  • chest pain, pressure or tightness (angina);
  • pain that spreads to the neck, jaw, shoulders or arms;
  • shortness of breath;
  • unusual tiredness, feeling faint or feeling sick.

Chest pain that does not go away, or that comes on at rest, may be a heart attack: call the emergency number straight away.

How doctors find out

Your doctor asks about your symptoms, your family and your lifestyle, checks your blood pressure, and does blood tests for cholesterol and sugar. A risk score can estimate your chance of a heart attack or stroke in the next 10 years. Tests that can confirm it include an ECG, an echocardiogram, a chest X-ray, and a coronary angiogram, which is an X-ray that checks the blood vessels.

Current treatment

Treatment combines lifestyle changes with medicines such as blood thinners, statins and blood pressure medicines, and some people also need angioplasty with a stent or bypass surgery.

Will it get worse?

The symptoms can get worse over time as more fatty deposits build up. Over time it can lead to angina, a heart attack, heart failure or an irregular heartbeat. A healthy lifestyle may slow the disease down, and treatment can help reduce the chances of problems such as a heart attack.

Medicines: what helps, and what to watch for

Many different medicines are used to treat heart disease. Blood thinners such as low-dose aspirin or clopidogrel stop clots forming and lower the risk of a heart attack. Statins lower cholesterol. Beta blockers slow the heartbeat and help with angina. Nitrates widen the blood vessels and ease chest pain. Other medicines lower blood pressure.

Good to know:

  • nitrates can cause mild headaches, dizziness and flushed skin;
  • ACE inhibitors, such as ramipril, can cause a dry cough and dizziness, and you need regular blood tests to check your kidneys;
  • calcium channel blockers can cause headaches and a flushed face, which are usually mild and short-lived.

Exercise and therapy help too

  • cardiac rehabilitation after a heart attack: often weekly sessions that last 6 to 12 weeks, in a group, online or at home, with suitable exercise, advice on taking your medicines, stress management and support for anxiety and low mood;
  • people who go to cardiac rehabilitation are less likely to have another heart attack or go into hospital;
  • be active, eat a healthy, balanced diet and keep a healthy weight;

Procedures and surgery, for some people

In a coronary angioplasty, a small balloon pushes the fatty deposits outwards to widen a narrowed artery, and a small metal tube (stent) is usually left in to keep it open. It can be planned, or done urgently during a heart attack. In bypass surgery, a blood vessel is attached so that blood can flow around the narrowed or blocked part. Occasionally a heart transplant may be needed, when the heart is severely damaged and medicines do not work, or when the heart cannot pump enough blood.

Is there a cure?

No. Coronary heart disease cannot be cured, but treatment eases the symptoms and lowers the chance of a heart attack.

See the 1,538 trials you can join